BONOTHYRK lingual

Bonothyrk® lingual, a natural peptide complex for the parathyroid gland. Contains a complex of parathyroid gland peptide fractions. The drug belongs to the class of natural potent long-acting geroprotectors obtained from the parathyroid glands of young animals. This concentrated peptide complex has a selective effect on parathyroid gland cells, normalises intracellular metabolism and increases their functional activity.

The parathyroid glands play a key role in regulating calcium and phosphorus metabolism, controlling blood calcium levels and bone mineralisation processes. Disruptions in the functioning of these small but important glands can have serious consequences for the entire body. Hyperfunction leads to osteoporosis, kidney stones and muscle weakness. Insufficient activity causes painful muscle spasms, numbness in the limbs and heart rhythm disturbances.

Bonothyrk® acts specifically on the cells of the parathyroid glands, restoring their ability to respond adequately to changes in calcium levels in the body. Peptide bioregulators normalise parathyroid hormone synthesis, improve cell sensitivity to calcium and restore the natural mechanisms of mineral metabolism regulation. This is especially important for older people, when age-related changes often lead to bone metabolism disorders and an increased risk of fractures.

Clinical studies have established the effectiveness of Bonothyrk lingual in restoring the functional activity of the parathyroid glands in pathological disorders of various origins, including hyperparathyroidism, osteoporosis, bone demineralisation, urolithiasis, muscle weakness, as well as in hypoparathyroidism, including hypocalcaemia, muscle spasms, muscle numbness, as well as for complex rejuvenation of the body.

The lingual form of the drug has a higher degree of bioavailability and speed of inclusion, as well as a more flexible dosage.

Also found by queries: bonotirk, bonathyrk, peptides for parathyroid.

FIELD OF APPLICATION:

• hyperparathyroidism / hypoparathyroidism
• bone demineralisation
• osteoporosis
• urolithiasis
• muscle weakness, parathyroid hyperplasia
• muscle spasms, muscle numbness, hypocalcaemia
• complex rejuvenation of the body

ACTIVE COMPONENTS:

Peptide complex A-21.

HOW TO USE AND DOSAGE:

Place 10 drops under the tongue twice daily, 5-10 minutes before meals.
Treatment duration is 1 month.

If required, the course may be repeated after a 1-2 month interval.
The recommended daily dose is 1 ml, containing 10 mg of active ingredient.

Hold the drops under the tongue for optimal sublingual absorption. Do not swallow immediately - allow the active compounds to absorb through the oral mucosa for maximum therapeutic benefit. This method ensures direct entry into the systemic circulation, bypassing hepatic metabolism and providing faster onset of action.

For best results, maintain consistent timing of administration.

PACKING:

tube 0.33 fl.oz (10 ml) / product: Bonothyrk lingual / Non-GMO. Not a medicinal product.